cancer.dk

Upcoming DCRC seminars

Upcoming Seminars:

2016
Thursday 8 December at 14:00	Peter James Department of Immunotechnology, University of Lund, Sweden A mechanistic approach to Breast Cancer: Defining molecular subtypes and following adjuvant therapy treatment response More information
To be announced	Marisol Soengas Spanish National Cancer Research Center (CNIO), Madrid, Spain Validation of novel anticancer agents in mice engineered for non-invasive imaging of pre-metastatic niches More information

Other seminars in the Copenhagen Area:

For the quick overview of upcoming seminars, go to our common BioMed Calendar

Looking for something specific? Check out

DanStem Seminar Series

Novo Nordisk Center for Protein Research

BRIC

Danish Stem Cell Society Symposium

Past DCRC seminars:

2016
October 7	Anthony Chalmers University of Glasgow, UK Characterising and targeting the DNA damage response in glioblastoma stem like cells in 2D & 3D and in the brain More information
September 2	Jeremy Rich Lerner Research Institute, Cleveland OH, USA Dynamic Complexity of Brain Tumor Stem Cells More information
June 7	Massimo Lopes University of Zürich, Switzerland Replication fork remodelling upon replication stress in cancer and stem cells More information
May 27	Vanessa Didelez University of Bristol, UK Causal Reasoning for Events in Continuous Time - Application to Cancer Screening in Norway More information
May 18	Poul Sorensen BC Cancer Research Center, Vancouver, Canada Beyond the Transcriptome: Selective mRNA Translation as a Driver of Tumor Plasticity and Aggressive Behaviour More information
April 20	Michael Overholtzer Memorial Sloan Kettering Cancer Center, New York, USA Starving cells to death More information
April 15	Anne Marie Ellegaard & Søren Friis Danish Cancer Society Research Center Towards better translational research - combining laboratory and epidemiologic analyses. Examplified by the project "Repurposing cationic amphiphilic histamines for cancer therapy More information
April 1	John Witte Dept. of Epidemiology/Biostatistics and Urology, UCSF Genetically adjusting PSA levels to improve prostate cancer screening More information
March 4	Estela Jacinto Rutgers Robert Wood Johnson Medical School, Piscataway, NJ, USA mTOR complex 2 in cell metabolism More information

2015
December 4	Ivan Dikic Institute of Biochemistry II, Goethe University, Frankfurt, Germany Ubiquitin and Autophagy networks in Health and Disease More information
November 27	Jacco van Rheenen Hubrecht Institute, Utrecht, The Netherlands Intravital imaging reveals the dynamic nature of tumor heterogeneity More information
November 13	Claus Thorn Ekstrøm Section of Biostatistics, Department of Public Health, University of Copenhagen Heritability - the good, the bad, and the ugly More information
May 29	David Needham Center for Single Particle Science and Engineering, University of Southern Denmark Endogenous-Inspired Hydrophobic Drug Delivery to Cancers: LDL-like Nano Particles Designed to "Put the Drug in the Cancer's Food" More information
May 22	Mazda Jenab Nutritional Epidemiology Group, IARC Exploring the Role of Dietary and Metabolic Factors in Liver Cancer Development More information
April 24	Kjeld Schmiegelow Pediatric Oncology, Copenhagen University Hospital The host and the cancer genome - aspects of individualized therapy. Lessons from childhood leukemia More information
April 17	Mesut Bilgin CARD/Danish Cancer Society Research Center Introduction to Lipidomics application for quantitative characterization of the biological lipidome More information
April 13	Thanos Halazonetis University of Geneva, Switzerland Mechanisms of oncogene-induced DNA replication stress More information
March 6	Søren Brunak Disease Systems Biology, NNF Center for Protein Research, University of Copenhagen Center for Biological Sequence Analysis, Dept. of Systems Biology, Technical University of Denmark Coupling registry data with molecular systems biology in cancer and beyond Moreinformation
January 16	Olaf M. Dekkers Leiden University Medical Center, The Netherlands Department of Clinical Medicine, Aarhus University Causality: Should epidemiologists bother about philosophy? More information
January_____9	Holly Prigerson Weill Cornell Medical College, USA Psychosocial issues in end of life care More information

2014
December 18	Justin Lathia Cleveland Clinic Lerner Research Institute, USA Cracking the cancer stem cell communication code More information
December 12	Vilhelm Bohr National Institute of Aging, NIH, USA Nuclear-mitochondrial DNA damage signaling and age-associated disease More information
November 25	Joachim Schüz International Agency for Research on Cancer (IARC) Twelve ways to reduce your risk of cancer: 4th edition of the European Code against cancer More information
November 14	Marie Stampe Ostenfeld Aarhus University Exosomes in tumor spread and as circulating cancer biomarkers More information
October 31	Christine J. Watson University of Cambridge, UK Die another way - lysosomal cell death in mammary gland More information
October 3	Pascal Meier The Institute of Cancer Research, London, UK Cell death, inflammation, and adaptation to tissue stress More information
September 24	Felix Randow MRC Laboratory of Molcular Biology, Cambridge, UK How cells deploy autophagy to defend their cytosol aginst invading bacteria More information
September 12	Luca Scorrano University of Padua and Venetian Institute of Molecular Medicine, Italy Keeping mitochondria in shape: a matter of life and death More information
June 24	Kanaga Sapabathy National Cancer Center Singapore, National University of Singapore p73: a bona-fide tumor suppressor or one in disguise? More information
May 23	Alexander Loewer Max-Delbrück Center for Molecular Medicine, Berlin, Germany The guardian on the move: p53 dynamics and function in single cells More information
May 9	Bas Heijmans Leiden University Medical Center, the Netherlands The prenatal epigenome and studies into long-term health More information
April 11	Douglas Easton University of Cambridge, UK Understanding the genetics of breast cancer More information
April 4	Jan P. Vandenbroucke Leiden University Medical Center, The Netherlands What can we learn from an example of gene-environment interaction? Workshop: Epidemiological exercise on Factor V Leiden and venous thrombosis More information
March 7	Bendix Carstensen Steno Diabetes Center, Clinical Epidemiology Group, Copenhagen, Denmark The Epidemiology of Diabetes and Cancer More information
February 4	Douglas R. Green St. Jude Children's Research Hospital, Memphis, TN, USA LC3-Associated Phagocytosis: Two ancient pathways meet at the crossroads of innate immunity, inflammation, and aging More information
January___24	Oscar Fernandez-Capetillo Spanish National Cancer Research Centre, Madrid, Spain Exploring the role of the SMC5/6 complex in the suppression of cancer and ageing in mammals More information

2013
November 22	Andrea Ballabio Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy the lysosome as a control center for cellular clearance eand energy metabolism More information
November 14	Frances Platt University of Oxford, UK Lysosomal disorders: pathogenesis and therapy More information
November 25	Joachim Schüz International Agency for Research on Cancer (IARC) Twelve ways to reduce your risk of cancer: 4th edition of the European Code against cancer More information
November 8	Henrik Møller King's College, London, UK Aetiological and clinical cancer epidemiology: with recent examples from prostate, lung and breast cancer More information
November 1	Frances Balkwill Barts Cancer Institute, London, UK The ovarian cancer microenvironment More information
October 4	Jan Paul Medema Academic Medical Center, Amsterdam, The Netherlands Colon cancer heterogeneity - cancer stem cells and distinct subsets More information
September 20	John Doorbar National Institute for Medical Research, London, UK The human papillomavirus life cycle - regulation and deregulation More information
August 30	Jos Jonkers Netherlands Cancer Institute, Amsterdam, The Netherlands Studying therapy response and resistance in mouse models of breast cancer More information
August 16	Mads Daugaard British Columbia Cancer Agency, Vancouver, Canada Malignancy-associated stress signaling pathways - novel ways to intervene More information
June 14	Rosemary O'Connor University of College Cork, Ireland IGF-1 signalling - the good, the bad and the essential More information
May 31	Gerard Evan University of Cambridge, UK Using switchable mouse genetics to identify the best cancer drug targets More information
May 24	Henrik Ullum & Henrik Hjalgrim Department of Clinical Immunology, Rigshospitalet & Department of Epidemiology Research, Statens Serum Institut, Copenhagen The Danish Blood Donor Study - a large national platform for collaborative health research More information
May 16	Johanna Joyce Memorial Sloan-Kettering Cancer Center, New York, USA Exploring and exploiting the functions of macrophages in the tumor microenvironment More information
April 25	Mikala Egeblad Cold Spring Harbor Laboratory, NY, USA Caught in the act: the functions of stromal villains and heroes in cancer progression and drug resistance illuminated through imaging More information
April 19	Theis Lange University of Copenhagen, Denmark Mediation analysis in cancer research - a stepping stone on the path from association to causal understanding More information
April 12	Alexei Kirkin Danish Cancer Society Research Center A new epigenetic approach to immunotherapy and its use for treatment of late-stage glioblastoma and prostate cancer More information
March 15	Irving Weismann Stanford University, CA, USA Normal and Neoplastic Stemm Cells More information
February 8	Henrik Hasle Aarhus University Hospital, Skejby, Denmark Myeloid Leukemia in Children - From epidemiology to molecular complexity More information
January___18	Kum Kum Khanna Queensland Institute of Medical Research, Brisbane, Australia Novel approaches for targeted treatment of triple-negative breast cancers More information

2012
November_30	Jerry E. Chipuk Mount Sinai Hospital, New York, USA Cellular addiction to oncogenic signaling suppresses mitochondrial function More information
November 20	Guanglian Yin BGI, Shenzen, China BGI next-generation sequencing for cancer research studies More information
June 21	Ameeta Kelekar University of Minnesota Mosonic Cancer Center, Minneapolis, MN, USA A novel mechanism for metabolic reprogrammin in proliferating T leukemia cells and thymocytes More information

Til top